AFT Pharmaceutical's multi-billion R&D opportunity
Welcome to HotCopper’s latest Watchlist, where we’ve been joined by AFT Pharmaceuticals (ASX:AFP) founder and chief executive Hartley Atkinson to discuss its expanding global reach and the @tentative” FDA approval the company has just hauled i...
Market Cap $158.4M
!
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Last update - 11.13am 06/08/2026 (20 minute delay)
?
| Day | ||||||||
|---|---|---|---|---|---|---|---|---|
| Open | 7.8¢ | Day High | 7.9¢ | Day Low | 7.8¢ | |||
| Daily Volume | 274824 | |||||||
| Bids | Sellers | |||||
|---|---|---|---|---|---|---|
| Number | Price | Volume | Number | Price | Volume | |
| 0 | 7.8¢ | 30000 | 0 | 7.9¢ | 94087 | |
Directors & Senior Management
| Mr. James Edward Marsh | Chief Executive Officer |
| Dr. John Vogrin | Head of Projects, Research & Development |
| Mr. Neville John Bassett | Company Secretary |
| Mr. Peter Zardo | MD & Director |
| Mr. Robert Hartley Downey | Independent Non-Executive Director |
| Mr. Scott Burkhart | Chief Operating Officer |
| Mr. Shane Michael Graham | Executive Director of Technical & Non-Independent Executive Director |
| Ms. Sylvia Medlyn Tulloch | Independent Non-Executive Chairman |
| Mr. Tim Anderson | Chief Commercial Officer & GM |
Data source: ADVFN
